117 related articles for article (PubMed ID: 7617059)
1. [Intravenously administered high-dose glucocorticosteroids in active rheumatoid arthritis].
Jacobs JW; Weusten BL; Bijlsma JW
Ned Tijdschr Geneeskd; 1995 Jul; 139(27):1370-6. PubMed ID: 7617059
[No Abstract] [Full Text] [Related]
2. Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study.
Aviña-Zubieta JA; Abrahamowicz M; Choi HK; Rahman MM; Sylvestre MP; Esdaile JM; Lacaille D
Ann Rheum Dis; 2011 Jun; 70(6):990-5. PubMed ID: 21367762
[TBL] [Abstract][Full Text] [Related]
3. Low-dose glucocorticoid therapy in rheumatoid arthritis.
Trèves R
Rev Rhum Engl Ed; 1995 Nov; 62(10):611-7. PubMed ID: 8624668
[No Abstract] [Full Text] [Related]
4. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM;
Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids in early rheumatoid arthritis.
Davey M; Buchbinder R
Aust Fam Physician; 2008; 37(1-2):31-2. PubMed ID: 18239749
[TBL] [Abstract][Full Text] [Related]
6. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study.
Hafström I; Rohani M; Deneberg S; Wörnert M; Jogestrand T; Frostegård J
J Rheumatol; 2007 Sep; 34(9):1810-6. PubMed ID: 17696277
[TBL] [Abstract][Full Text] [Related]
7. [Current status of corticoid therapy of rheumatoid polyarthritis].
Dutu Al; Boloşiu HD; Căprioară
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(5):365-72. PubMed ID: 242066
[No Abstract] [Full Text] [Related]
8. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.
Davis JM; Maradit Kremers H; Crowson CS; Nicola PJ; Ballman KV; Therneau TM; Roger VL; Gabriel SE
Arthritis Rheum; 2007 Mar; 56(3):820-30. PubMed ID: 17330254
[TBL] [Abstract][Full Text] [Related]
9. Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis.
Metselaar JM; Wauben MH; Boerman OC; Van Lent PL; Storm G
Cell Mol Biol Lett; 2002; 7(2):291-2. PubMed ID: 12097962
[No Abstract] [Full Text] [Related]
10. Glucocorticoids in rheumatoid arthritis: a senescent research agenda on the brink of rejuvenation?
Boers M
Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):21-9. PubMed ID: 15123035
[TBL] [Abstract][Full Text] [Related]
11. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
12. [Changes in certain biochemical markers of bone turnover in rheumatoid arthritis patients treated with short-term low dose glucocorticosteroids].
Korczowska I; Lacki JK
Przegl Lek; 2005; 62(12):1384-6. PubMed ID: 16786754
[TBL] [Abstract][Full Text] [Related]
13. [Advantages and disadvantages of intra-articular injections].
Hirohata K; Ishikawa K
Ryumachi; 1977 Dec; 17(6):591-93. PubMed ID: 609944
[No Abstract] [Full Text] [Related]
14. Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.
Nishimoto N; Yoshizaki K; Maeda K; Kuritani T; Deguchi H; Sato B; Imai N; Suemura M; Kakehi T; Takagi N; Kishimoto T
J Rheumatol; 2003 Jul; 30(7):1426-35. PubMed ID: 12858437
[TBL] [Abstract][Full Text] [Related]
15. The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: comment on the editorial by Harris.
Jacobs JW; Boers M; Kirwan JR; Bijlsma JW
Arthritis Rheum; 2006 Jun; 54(6):2031-2; author reply 2032. PubMed ID: 16732571
[No Abstract] [Full Text] [Related]
16. Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment.
Naumann L; Huscher D; Detert J; Spengler M; Burmester GR; Buttgereit F
Ann Rheum Dis; 2009 Dec; 68(12):1934-6. PubMed ID: 19910303
[No Abstract] [Full Text] [Related]
17. [What is the status of intra-articular corticoid therapy in the current treatment of rheumatoid arthritis?].
Krause A
Internist (Berl); 1993 Dec; 34(12):1156. PubMed ID: 8106212
[No Abstract] [Full Text] [Related]
18. [A long experience in basic therapy of rheumatoid arthritis].
Bokarev IN; Kanevskaia MZ
Klin Med (Mosk); 1997; 75(7):22-5. PubMed ID: 9411047
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory, active rheumatoid arthritis.
Matteson EL; Orces CH; Duffy J; Lipsky JJ; Pike MG; Sandborn WJ
Arthritis Rheum; 1999 Jan; 42(1):186-7. PubMed ID: 9920030
[No Abstract] [Full Text] [Related]
20. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
Davis JM; Maradit-Kremers H; Gabriel SE
J Rheumatol; 2005 Oct; 32(10):1856-62. PubMed ID: 16206334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
